Expression, purification, and evaluation of recombinant LecA as a candidate for an amebic colitis vaccine
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- COMMENTARY: Acceptable Levels of Endotoxin in Vaccine Formulations During Preclinical ResearchJournal of Pharmaceutical Sciences, 2011
- Protection against Intestinal Amebiasis by a Recombinant Vaccine Is Transferable by T Cells and Mediated by Gamma InterferonInfection and Immunity, 2009
- Intranasal Immunization with Gal-Inhibitable Lectin plus an Adjuvant of CpG Oligodeoxynucleotides Protects against Entamoeba histolytica ChallengeInfection and Immunity, 2007
- CpG-Oligodeoxynucleotide Is a Potent Adjuvant with anEntamoeba histolyticaGal-Inhibitable Lectin Vaccine against Amoebic Liver Abscess in GerbilsInfection and Immunity, 2006
- Intermediate Subunit of the Gal/GalNAc Lectin of Entamoeba histolytica Is a Member of a Gene Family Containing Multiple CXXC Sequence MotifsInfection and Immunity, 2001
- Amebiasis and Mucosal IgA Antibody against theEntamoeba histolyticaAdherence Lectin in Bangladeshi ChildrenThe Journal of Infectious Diseases, 2001
- Recent Advances in AmebiasisCritical Reviews in Clinical Laboratory Sciences, 1996
- A Redescription of Entamoeba Histolytica Schaudinn, 1903 (Emended Walker, 1911) Separating It From Entamoeba Dispar Brumpt, 19251Journal of Eukaryotic Microbiology, 1993
- Isolation of the galactose-binding lectin that mediates the in vitro adherence of Entamoeba histolytica.Journal of Clinical Investigation, 1987
- A new medium for the axenic cultivation of Entamoeba histolytica and other EntamoebaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1978